Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Hong Kong · Delayed Price · Currency is HKD

0.9600

0.00 (0.00%)

Oct 9, 2026, 3:51 PM HKT

Market Cap	1.45B -23.0%
Revenue (ttm)	1.32B +3.0%
Net Income	268.70M +31.9%
EPS	0.18 +30.0%
Shares Out	1.51B
PE Ratio	5.46
Forward PE	n/a
Dividend	0.06 (6.56%)
Ex-Dividend Date	Sep 22, 2026

Volume	728,000
Open	0.9550
Previous Close	0.9600
Day's Range	0.9500 - 0.9600
52-Week Range	0.9500 - 1.2600
Beta	0.26
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines for various therapeutic areas, such as cardiovascular syst... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1995

Employees 1,074

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2348

Full Company Profile

Financial Performance

In 2025, HKG:2348's revenue was 1.23 billion, an increase of 16.09% compared to the previous year's 1.06 billion. Earnings were 213.97 million, a decrease of -62.13%.

Financial numbers in CNY Financial Statements